Medicine and Dentistry
Cell Line
100%
Breast Cancer
100%
DNA Damage Response
100%
Promoter Region
75%
Methylation
75%
Chemosensitivity
75%
Decitabine
75%
CRISPR Associated Protein
75%
In Vitro
50%
Cancer Cell
50%
Cancer Cell Line
50%
Interferon
50%
Clustered Regularly Interspaced Short Palindromic Repeat
25%
Neoplasm
25%
Downregulation
25%
Breast Cancer Cell Line
25%
Cancer Types
25%
Cellular Model
25%
Immunocompetent Cell
25%
Cisplatin
25%
Olaparib
25%
Upregulation
25%
Epirubicin
25%
Demethylation
25%
Immunology and Microbiology
Cell Line
100%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
DNA Damage Response
100%
Methylation
75%
Promoter Region
75%
Chemosensitivity
75%
Cancer Cell
50%
Cancer Cell Line
50%
interferon
50%
Upregulation
25%
Breast Cancer Cell Line
25%
Downregulation
25%
Immunocompetent Cell
25%
Coculture
25%
Drug Concentration
25%
Demethylation
25%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
DNA Damage Response
100%
CRISPR
80%
Promoter Region
60%
Methylation
60%
Decitabine
60%
Chemosensitivity
60%
Interferon
40%
Upregulation
20%
Downregulation
20%
Cisplatin
20%
Immunocompetent Cell
20%
Coculture
20%
Demethylation
20%
Epirubicin
20%
Drug Concentration
20%
Keyphrases
Breast Cancer
100%
Family Members
100%
DNA Damage Response
100%
Schlafen
100%
DNA Damage
14%
Chemosensitivity
14%
CRISPR-associated Protein 9
14%
Breast Cancer Cells
9%
Methylation
9%
Cancer Cell Lines
9%
Decitabine
9%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
4%
Immune Cells
4%
Targeted Therapy
4%
Breast Cancer Cell Lines
4%
RNA Sequencing (RNA-seq)
4%
Improved Outcomes
4%
Cisplatin
4%
Cancer Types
4%
Cellular Models
4%
Antitumor Immune Response
4%
High Sensitivity
4%
Olaparib
4%
Promoter Region
4%
Promoter Methylation
4%
BT549
4%
Transcriptomics
4%
Interferon-α (IFN-α)
4%
T47D
4%
MDA-MB-231
4%
Personalized Approach
4%
Mechanism of Action
4%
Stimulator of Interferon Genes (STING)
4%
Demethylation
4%
Response Sensitivity
4%
Epirubicin
4%
In Vitro Effect
4%
Multiple Cell Lines
4%
Indirect Coculture
4%
Genomic Determinants
4%
Modified Cells
4%
T47D Cells
4%
BT-549 Cells
4%
Drug Concentration
4%
5-aza-2′-deoxycytidine
4%
Non-lethal
4%
Refractory Cancer
4%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
CRISPR Associated Protein
60%
Decitabine
60%
Interferon
40%
Neoplasm
20%
Cisplatin
20%
Epirubicin
20%
Drug Concentration
20%
Olaparib
20%